The American Society of Clinical Oncology recently held its annual conference in Chicago where pharmaceutical companies touted new cancer therapies and potential breakthroughs, however many speakers were focused on the skyrocketing costs of cancer drugs, calling for the explicit consideration of cost-effectiveness in the drug approval and insurance coverage process. Read more here. (Source: Sabriya Rice, Steven Ross Johnson, Modern Healthcare, 6/2/15)
You are here: Home / Comparative Effectiveness Research / Will Oncologists’ Push for Cost-Effectiveness Help Lower Pricing?
